Home»Exposition»Global Cancer Immunotherapies Markets, 2017 – Regulatory and Reimbursement Policy Shifts Favor First-in-Class Product Innovation

Global Cancer Immunotherapies Markets, 2017 – Regulatory and Reimbursement Policy Shifts Favor First-in-Class Product Innovation

0
Shares
Pinterest Google+
Research and Markets Logo

DUBLIN, October 12, 2017 /PRNewswire/ —
The “Frontier Pharma: Cancer Immunotherapies – First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets” drug pipelines has been added to Research and Markets’ offering.
The report “Frontier Pharma: Cancer…

Previous post

Global Service Robotics Market Report 2017-2025

Next post

Global $41 Bn Respiratory Drugs Market to 2023 - Leading Players are GSK, AstraZeneca and Boehringer Ingelheim